PlainRecalls
FDA Drug Moderate Class II Terminated

Raloxifene Hydrochloride Tablets, USP, 60 mg, 30 Tablets (3 x 10 blister cards), Rx Only, Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC carton: 60687-266-21; NDC Unit Dose: 60687-266-11

Reported: February 19, 2020 Initiated: December 4, 2019 #D-0854-2020

Product Description

Raloxifene Hydrochloride Tablets, USP, 60 mg, 30 Tablets (3 x 10 blister cards), Rx Only, Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC carton: 60687-266-21; NDC Unit Dose: 60687-266-11

Reason for Recall

Failed Dissolution Specifications: Low out of specification results obtained during stability testing.

Details

Recalling Firm
American Health Packaging
Units Affected
973 cartons
Distribution
Nationwide within the United States
Location
Columbus, OH

Frequently Asked Questions

What product was recalled?
Raloxifene Hydrochloride Tablets, USP, 60 mg, 30 Tablets (3 x 10 blister cards), Rx Only, Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC carton: 60687-266-21; NDC Unit Dose: 60687-266-11. Recalled by American Health Packaging. Units affected: 973 cartons.
Why was this product recalled?
Failed Dissolution Specifications: Low out of specification results obtained during stability testing.
Which agency issued this recall?
This recall was issued by the FDA Drug on February 19, 2020. Severity: Moderate. Recall number: D-0854-2020.